ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CTXR Citius Pharmaceuticals Inc

0.6825
0.0269 (4.10%)
01 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Citius Pharmaceuticals Inc NASDAQ:CTXR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0269 4.10% 0.6825 0.6825 0.70 0.71 0.66 0.66 1,969,316 00:57:37

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

26/01/2024 9:08pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934

 

Filed by the Registrant

Filed by a Party other than the Registrant

 

Check the Appropriate Box:

 

☐  Preliminary Proxy Statement
☐  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐  Definitive Proxy Statement
☒  Definitive Additional Materials
☐  Soliciting Material Under Rule 14a-12

 

Citius Pharmaceuticals, Inc.

 

(Name of Registrant as Specified in Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

☒  No fee required.
   
☐  Fee paid previously with preliminary materials:
   
☐  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

 

 

 

 


1 Year Citius Pharmaceuticals Chart

1 Year Citius Pharmaceuticals Chart

1 Month Citius Pharmaceuticals Chart

1 Month Citius Pharmaceuticals Chart